Ward 86 shares *updated* clinical considerations and recommendations for starting patients on CAB/RPV LA therapy

2022 Spring Consortium Meeting: The Tenderloin – voices from the field
May 23, 2022
Show all

Ward 86 shares *updated* clinical considerations and recommendations for starting patients on CAB/RPV LA therapy

Ward 86, established in January 1983, is a large HIV clinic based at San Francisco General Hospital at the University of California, San Francisco (UCSF). Ward 86 serves a publicly-insured and underinsured population of people with HIV and those at risk of HIV in the city of San Francisco.

Purpose of this protocol

  • Provide guidance to clinicians on long-acting injectable cabotegravir/rilpivirine (CAB/RPV LA) for their patients
  • Establish a workflow for referral, initiation, and management of patients starting CAB/RPV LA
  • Provide guidance to clinicians on education to patients who will receive CAB/RPV LA
  • Provide guidance on care coordination, including clinic appointments and follow-ups, for patients on CAB/RPV LA

Here is a link to the updated full-text protocol: https://gettingtozerosf.org/wp-content/uploads/2022/10/Ward-86-LA-ART-Protocol-SPLASH-10-26-22.pdf

This is a resource that can be adapted to your city or jurisdiction’s needs.

Please email contact@gettingtozerosf.org if you have questions for the Ward 86 HIV Clinic or the Co-Chairs of the GTZ-RAPID Committee Dr. Susa Coffey (susa.coffey@ucsf.edu) and Miguel Ibarra (miguel@sfcommunityhealth.org).

Comments are closed.